Edit

Panakes Partners

http://www.panakes.it

Last activity: 09.10.2024

Probably Closed

Invests in categories: MedTechHardwareTechnologyProductPlatformITHealthTechDevelopmentRoboticsLife

News

Portfolio

Persons

Mentions

Location: Italy, Lombardy, Milan

Employees: 11-50

Investment Type: Venture Capital

Investment Stage: Pre-Seed; Seed; Series A

Portfolio 18

Date	Name	Website	Total Raised	Location
29.11.2023	Nouscom AG	nouscom.com	$135.77M	Switzerlan...
26.10.2023	Approxima	approximamedical.com	-	Italy, Lom...
02.08.2023	Allotex	allotex.com	-	United Sta...
02.08.2023	EBAMed	eba-med.com	$16.94M	Switzerlan...
01.05.2023	Complement...	complementtx.com	$84.66M	United Kin...
11.08.2022	Vivasure M...	vivasuremedical.com	$73.84M	Ireland, G...
11.08.2022	SamanTree ...	samantree.com	$30.43M	United Sta...
10.04.2022	Neuromod D...	neuromoddevices.com	$60.56M	Ireland, D...
21.12.2018	DIADEM DX	diademdx.com	$12.75M	Italy, Lom...
-	Carthera	carthera.eu	$64.82M	France, Il...
-	Aileens Ph...	aileenspharma.com	$3.52M	Italy, Lom...
-	MMI	mmimicro.com	$127.65M	Italy
-	Endostart	endostart.com	$11.13M	Italy, Tus...
-	BetaGlue T...	betaglue.com	-	Italy, Lom...
-	Echolight	echolight.it	$4.53M	Germany, B...
-	Salvia Bio...	salvianeuro.com	$30.44M	Netherland...
-	Alesi Surg...	alesi-surgical.com	$13.38M	-
-	InnovHeart	innovheart.com	$78.58M	-

Persons 1

Date	First Name	Last Name	Title	LinkedIn	Twitter	Email
-	Michela	Barcella	Network an...	linkedin.c...	-	i*********...

News 37

Mentions in press and media 18

Date	Title	Description
09.10.2024	Lymphatica Medical raises €17.9 million in series B Funding	First of its kind, LymphoDrain is easy to implant subcutaneously through a minimally invasive technique and it’s intended to provide unprecedent benefits to patients by locally and actively replacing the lymphatic vessels draining function...
12.09.2024	CorFlow Therapeutics Secures €44 Million to Revolutionize Heart Attack Treatment	CorFlow Therapeutics is on a mission. The Swiss company has just raised €44 million in a Series B funding round, co-led by Broadview Ventures and Panakes Partners. This influx of capital is not just a financial boost; it’s a lifeline for pa...
12.09.2024	CorFlow Therapeutics raises €44 million in Series B round	Co-led by Broadview Ventures and Panakes Partners, CoFlow’s series B round received strong continued support from 415 Capital, its initial VC investor and largest shareholder. Merieux Equity Partners, Laerdal Million Lives Fund, Wellington...
17.07.2024	SamanTree Medical makes strategic changes after $14M round	From biopsy taking to surgical diagnosis, tissue assessment is a key component to efficient and straightforward cancer treatment. However, obtaining high-resolution results promptly remains a major challenge. SamanTree’s Histolog Scanner i...
14.11.2023	Nouscom raises CHF65 million in oversubscribed Series C financing round
28.06.2023	EUR 14.35 million to advance cardiac radiation ablation therapy
11.05.2023	Il mercato del Venture Capital ad aprile 2023	Come è andato il mercato del Venture Capital ad aprile 2023? Facciamo insieme una carrellata delle startup, delle scaleup e dei round più interessanti. Purtroppo, i dati del primo trimestre 2023 confermano i trend negativi in Europa per gli...
04.10.2021	Finanțări pentru startup-uri medicale europene prin fonduri de investiții de 1,7 miliarde Euro	Startup-urile și firme mai dezvoltate, care inovează în medicină și alte științe ale vieții, au la dispoziție finanțări totale 1,7 miliarde de euro, prin 8 fonduri de investiții europene, susținute de UE și de mari companii, precum Google. ...
14.04.2020	SwissDeCode selected by European Innovation Council for Covid-19 pitching event
14.04.2020	SwissDeCode selected by European Innovation Council for Covid-19 pitching event	SwissDeCode developed DNAFoil technology, a portable, self-administered, on-site DNA detection kit, which combines both food safety and compliance with regulatory bodies in a single tool.
07.05.2019	SamanTree Medical raises CHF 9.5m in Series A round
21.12.2018	Diadem, an academic spin-off active in early Alzheimer diagnostic, raises €1,5 million in its A Round led by Panakes Partners	Diadem, an academic spin-off active in early Alzheimer diagnostic, raises €1,5 million in its A Round led by Panakes Partners Panakès Partners has led an investment round of ca. €1,5 million in Diadem an innovative startup based in Milan an...
25.07.2018	Aileens Pharma Raises €3M in Series A Funding	Aileens Pharma S.r.l., a Milan, Italy-based developer of treatments to improve clinical outcomes in patients suffering from dermatological diseases, completed a €3M Series A financing. The round was led by Panakes Partners, alongside Invita...
07.09.2016	Seventeen Raises €4.2M in Series A Funding	Seventeen, a Naples, Italy-based medtech startup, raised €4.2m in Series A funding. Backers included Panakès Partners and Innogest. The company intends to use the funds to finalize the technology and clinically validate it in order to obtai...
09.03.2016	Panakès Partners Adds Barbara Castellano to the Investment Team	Panakès Partners SGR, a Milan, Italy-based medtech venture capital firm, announced that Barbara Castellano joined the investment team. Castellano brings 20 years of experience in Medtech, in particular in Cardiovascular, having held corpora...
22.02.2016	Panakès Partners, Interview with Founder Alessio Beverina	Panakès Partners (the name Panakès derives from Panacea – Greek Πανάκεια, Panakeia – who was the goddess of universal remedy, said to have a potion with which she healed the sick) is a Milan-based newly formed venture capital firm aiming to...
15.02.2016	Confirmed: Panakès Partners Launches Medtech Venture Capital Fund	As we anticipated last week, Milan, Italy-based Panakès Partners SGR SpA has launched its first medtech venture capital fund, Panakès Fund I, the first Italian EU Venture Capital Fund (EUVECA). After its second closing in January, Panakès n...
10.02.2016	Panakès Partners to Raise First Medtech Venture Capital Fund	Panakès Partners, a Milan, Italy-based venture capital firm focused on medtech, is to raise its first fund. The Panakès Fund I has already attracted support from the European Investment Fund, which follows the investment from Fondo Italiano...

Date	Title	Description
27.09.2021	PANAKÈS PARTNERS APPOINTS DR. ROB WOODMAN AS PARTNER TO LEAD BIOTECH INVESTMENT	PANAKÈS PARTNERS APPOINTS DR. ROB WOODMAN AS PARTNER TO LEAD BIOTECH INVESTMENT DR. ROB WOODMAN BRINGS 15 YEARS OF EXPERIENCE IN LIFE SCIENCE INVESTING AND A TRACK RECORD OF SUCCESS IN BOTH INSTITUTIONAL AND CORPORATE VENTURE CAPITAL • Pana...
28.07.2021	Panakes Partners Announces the hiring of Dr. Marco Sardina as Scientific Partner and Dr. Andrea Ballerini as Associate	Panakes Partners SGR, a leading Venture Capital investor creating and building the next generation of innovative European Life Science companies, announced today that Dr. Marco Sardina has joined the team as Scientific Partner and Dr. Andre...
20.07.2021	PANAKÈS PARTNERS ANNOUNCES THE FIRST CLOSING OF ITS NEW “PURPLE” GLOBAL BIOTECH/ MEDTECH	PANAKÈS PARTNERS ANNOUNCES THE FIRST CLOSING OF ITS NEW “PURPLE” GLOBAL BIOTECH/ MEDTECH FUND AT €150 MILLION ($180 MILLION) • Panakès will use the successful closing of its second Fund to extend its investment activity to biotech, while ma...
01.07.2021	Salvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announces today the appointment	Salvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announces today the appointment of Dr Alan Levy as Chairman of the Board of Directors. Dr Levy has 40 years of senior operation...
09.06.2021	CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces preclinical results	CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces preclinical results in the testing of the combination of SonoCloud® technology with immunotherapies. ...
04.06.2021	Endostart,startup toscana che ha sviluppato una piattaforma endoscopica che mira alle colonscopie incomplete, già certificata ISO13485	Endostart, startup toscana che ha sviluppato una piattaforma endoscopica che mira alle colonscopie incomplete, già certificata ISO13485, ha annunciato di aver chiuso, insieme a nuovi e già presenti investitori, un aumento di capitale di €8....
13.05.2021	Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD)	Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced new data showing that its AlzoSure® prognostic biomarker test can accurately predict progression to Alzheimer'...
06.04.2021	Vivasure Medical®, a company pioneering fully absorbable solutions for large hole percutaneous vessel closure, today announced Andrew Glass has assumed the role of chief executive	Vivasure Medical®, a company pioneering fully absorbable solutions for large hole percutaneous vessel closure, today announced Andrew Glass has assumed the role of chief executive officer. Founder and former CEO Ger Brett will transition to...
12.03.2021	Panakès Partners sgr, società di venture capital specializzata in investimenti in aziende innovative nel settore delle scienze della vita, ha nominato partner Barbara Castellano	Panakès Partners sgr, società di venture capital specializzata in investimenti in aziende innovative nel settore delle scienze della vita, ha nominato partner Barbara Castellano e assunto con la carica di direttore finanziario Lorenzo Giord...
12.02.2021	Aileens Pharma, società di biotecnologia impegnata nella ricerca clinica, attiva nello sviluppo di trattamenti per le malattie della pelle	Aileens Pharma, società di biotecnologia impegnata nella ricerca clinica, attiva nello sviluppo di trattamenti per le malattie della pelle che colpiscono il microbioma cutaneo, ha annunciato la nomina di Mathieu Simon a presidente del Consi...
01.02.2021	Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced the publication of three new scientific studies	Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced the publication of three new scientific studies that support the utility of its biomarker assay to identify in...
12.01.2021	InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation, announced today the appointment	InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation, announced today the appointment of successful serial entrepreneur and medical device executive Dr. Azin...
12.01.2021	Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the hiring of Mark Toland	Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the hiring of Mark Toland as Chief Executive Officer. He brings more than 25 years of expe...
11.12.2020	Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today reported that it hosted a Symposium on its prognostic biomarker	Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today reported that it hosted a Symposium on its prognostic biomarker test at the 34th Annual Conference of Alzheimer's Diseas...
01.12.2020	Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced that noted neuroscientist and Alzheimer's	Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today announced that noted neuroscientist and Alzheimer's disease researcher Tamas Bartfai,PhD, has been named Chair of its Me...
25.11.2020	On the heels of its recent US launch, Echolight Medical announces the hiring of several industry heavyweights, not only in radiology but specifically in point-of-care service.	On the heels of its recent US launch, Echolight Medical announces the hiring of several industry heavyweights, not only in radiology but specifically in point-of-care service. Seattle-based Gina Raebel is VP of Marketing. Florida-based Alex...
03.11.2020	Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution	Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution Salvia BioElectronics B.V. ("Salvia"), a neurostimulation platform company targeting chronic migraine, announced today tha...
28.10.2020	MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World’s Smallest Wristed Surgical Instruments	MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World’s Smallest Wristed Surgical Instruments MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, annou...
19.10.2020	Diadem Names Clinical Diagnostics Industry Veteran Paul Kinnon as CEO	Diadem Names Clinical Diagnostics Industry Veteran Paul Kinnon as CEO Diadem srl, a company developing the first blood-based test for the prediction of early onset Alzheimer’s disease, today announced that Paul Kinnon has been named Chief E...
07.10.2020	EU backs MMI’s Robotic System for Microsurgery	EU backs MMI’s Robotic System for Microsurgery MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, has signed a financing agreement with the European Investment Bank (EIB) granting acce...
24.09.2020	InnovHeart Reports Successful First-in- Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up	InnovHeart Reports Successful First-in- Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatm...
22.09.2020	Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine	Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine Salvia BioElectronics B.V., a neurostimulation platform company targeting chronic migraine, today announced it has raised EUR...
14.09.2020	CarThera to receive €2M grant and €10.5M equity from the European Innovation Council	CarThera to receive €2M grant and €10.5M equity from the European Innovation Council CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces that it has been...
10.09.2020	Olympus Strikes Exclusive Deal to Distribute Ultravision Surgical Smoke Management System in the U.S.	Olympus Strikes Exclusive Deal to Distribute Ultravision Surgical Smoke Management System in the U.S. Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core...
07.08.2020	Transcatheter Mitral Valve Replacement Company InnovHeart Closes Series B Financing of €20 Million	Transcatheter Mitral Valve Replacement Company InnovHeart Closes Series B Financing of €20 Million InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, anno...
06.05.2019	SamanTree Medical Raises CHF 9.5 Million to Assess the Margins in Cancer Surgery	SamanTree Medical Raises CHF 9.5 Million to Assess the Margins in Cancer Surgery SamanTree Medical, committed to reducing the need for cancer1 surgery re-operation particularly in breast surgery, announced today the successful closing of it...
21.12.2018	Diadem, an academic spin-off active in early Alzheimer diagnostic, raises €1,5 million in its A Round led by Panakes Partners	Diadem, an academic spin-off active in early Alzheimer diagnostic, raises €1,5 million in its A Round led by Panakes Partners Panakès Partners has led an investment round of ca. €1,5 million in Diadem an innovative startup based in Milan an...
20.12.2018	Endostart, an Italian startup aiming at reducing endoscopic procedures’ complexity, raised €1 million in its seed round of financing	Endostart, an Italian startup aiming at reducing endoscopic procedures’ complexity, raised €1 million in its seed round of financing Panakès Partners led the round alongside of Estor, A11 Venture and sector business angels. Panakès Partners...
12.12.2018	CarThera closes €9M ($10.3M) Series B funding round	CarThera closes €9M ($10.3M) Series B funding round Funding will enable company to launch multi-center trial in patients with recurrent glioblastoma and develop clinical pipeline Paris, France, December 12, 2018 – CarThera, a French company...
18.07.2018	Aileens Pharma S.r.l. Announces €3M in Series A Funding to advance the development of a wave of Innovative Non-Steroidal Treatments for Dermatologic disorders	Aileens Pharma S.r.l. Announces €3M in Series A Funding to advance the development of a wave of Innovative Non-Steroidal Treatments for Dermatologic disorders 18 July 2018 - Milan. Aileens Pharma S.r.l. (Aileens), an Italian company dedicat...
18.04.2018	Medical Microinstruments S.p.A. Announces €20M in Series A Funding to Advance its Robotic Platform for Microsurgery	Medical Microinstruments S.p.A. Announces €20M in Series A Funding to Advance its Robotic Platform for Microsurgery Medical Microinstruments S.p.A. (MMI), an Italian company dedicated to improve clinical outcomes for patients undergoing mic...
31.05.2017	Alesi Surgical raises €6m (£5.2m) to accelerate commercialisation of breakthrough product UltravisionTM	Alesi Surgical raises €6m (£5.2m) to accelerate commercialisation of breakthrough product UltravisionTM Alesi Surgical Limited, the leading innovator of minimally invasive surgery technologies – including the world-first Ultravision device ...
07.09.2016	Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States	Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States Vivasure Medical™, a company developing a novel bioabsorbable technology for percutaneous vessel clos...
06.09.2016	Seventeen, a startup aiming to disrupt loco-regional therapies for solid tumors, raised a Series A for more than €4 million	Seventeen, a startup aiming to disrupt loco-regional therapies for solid tumors, raised a Series A for more than €4 million Panakès Partners and Innogest invested in interventional oncology Panakès Partners and Innogest led a €4.2 million f...
21.07.2016	Medtech Startup Echolight Raises €4M in Series A Funding	Echolight: from the South of Italy the first investment of Panakes Partners and the fifth investment of Invitalia Ventures. A 4M € Series A round in Echolight, the startup that revolutionize the diagnosis of osteoporosis Panakès and Invital...
08.03.2016	Panakès Partners SGR announces the arrival of Barbara CASTELLANO as part of the investment team	Barbara Castellano brings a significant 20-yearsexperience in Medtech, in particular in Cardiovascular, having held corporate senior positions at Sorin (now Livanova) and CID Cardiovascular (now Alvimedica). By leading strategic marketing, ...
15.02.2015	Partners SGR launches its first Venture Capital Fund dedicated to European Medtech startups.	At the end of 2015, Panakès Partners SGR SpA has obtained the required authorization by the competent authorities and has launched its first Fund, Panakès FundI. Investors in the Fund comprise a unique blend of major Italian and Internation...

Panakes Partners

Portfolio 18

Persons 1

News 37

Mentions in press and media 18

Reviews 0